Rare diseases require radical new funding methods

Devising funding strategies to develop drugs for the treatment of rare diseases remains a challenge as patient groups are often too small

Is accelerating drug trials a good idea?

Acceleration of drug trials offers the potential to bring life-prolonging treatments to patients more quickly, but some physicians warn that research risks being dumbed down

Understanding multiple sclerosis

Danny Buckland explains multiple sclerosis in plain language, and outlines treatments on offer and in development